Effects of pharmacological inhibition of fatty acid amide hydrolase on corticosterone release: a systematic review of preclinical studies
Abstract Psychiatric conditions are often linked to dysfunction of the Hypothalamic–Pituitary–Adrenal (HPA) axis. The Endocannabinoid System (ECS) plays a significant role in stress and anxiety and interacts with the HPA axis. The ECS metabolizing enzyme, Fatty Acid Amide Hydrolase (FAAH), may be in...
Saved in:
| Main Authors: | Christina F. Pereira, Isabelle Boileau, Stefan Kloiber |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-04-01
|
| Series: | Discover Mental Health |
| Online Access: | https://doi.org/10.1007/s44192-025-00155-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fatty acid amide hydrolase levels in brain linked with threat-related amygdala activation
by: Duncan GJ. Green, et al.
Published: (2022-06-01) -
Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling
by: Adrián Bartoll, et al.
Published: (2020-10-01) -
Synthesis and evaluation of isoquinolinyl and pyridinyl-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase to alleviate orofacial hyperalgesia in the rat
by: Daniel Carr, et al.
Published: (2025-06-01) -
Regulation of noradrenaline synthesis, uptake, and degradation in the left ventricle by fatty acid amide hydrolase (FAAH) inhibitor URB597 in the chronic unpredictable stress model of depression
by: Ferizović Harisa, et al.
Published: (2024-01-01) -
Endothelial soluble epoxide hydrolase links polyunsaturated fatty acid metabolism to oxidative stress and atherosclerosis progression
by: Minghua Cao, et al.
Published: (2025-09-01)